Teva’s Layoffs Signal Deeper Fault Lines In The Pharmaceutical Business Model

forbes.com/sites/ritanumerof/2025/06/02/tevas-layoffs-signal-deeper-fault-lines-in-the-pharmaceutical-business-model

The recent announcement that Teva Pharmaceuticals will lay off roughly 2,400 employees–approximately 8% of its global workforce–is a significant development in a sector already under strain. This move aims to save $700 million by 2027 as Teva attempts to rebalance its role as both a…

This story appeared on forbes.com, 2025-06-02 14:17:00.
The Entire Business World on a Single Page. Free to Use →